Tablets & Capsules

TC0419

Issue link: https://www.e-digitaleditions.com/i/1101841

Contents of this Issue

Navigation

Page 39 of 55

Nutraceutical tablet platforms Company offers two new nutraceutical tablet platforms based on its mineral excipient products. Omyasprint is an orally disintegrating tablet comprised of the company's Omyapharm multi- functional mineral excipient and vita- min B 12 that is designed to dissolve in the mouth in seconds without water. Omyapharm provides excellent carrier properties while also ensuring high mechanical stability and fast tablet dis- integration. Omyabone is a chewable tablet containing the company's Calci- pur excipient along with vitamins K 2 and D 3 . Calcipur is a high-purity natu- ral calcium source with 40 percent bio- available calcium that's suitable for manufacturing natural calcium supple- mentation and osteoporosis treatments. Omya, Cincinatti, OH 513 387 4600 www.omya-na.com Ingredients and nutraceutical excipients 32F April 2019 Tablets & Capsules Filler-binder galenIQ (isomalt) water-soluble filler-binder is suitable for manufacturing various solid dosage forms, such as chewable tablets, compressed lozenges, orally disinte- grating mini-tablets, and effervescents. Excipient is derived from sugar beet sucrose, giving it a sweet taste profile and pleasant mouthfeel that improves the palatability of bitter-tasting actives, plant extracts, and probiotics. Sugar-free excipient is non-cariogenic, has a low glycemic index, and can be used in products for diabetic patients. Filler-binder is easy to use, non-hygroscopic, chemically stable, and promotes high-content uniformity. Beneo, Parsipanny, NJ 973 867 2140 www.beneo.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0419